
Products
Approved / Marketed products
Flucytosine Capsules, USP 250 mg
Flucytosine Capsules, USP 500 mg
Disulfiram Tablets, USP 250 mg
Disulfiram Tablets, USP 500 mg
Ergocalciferol Capsules, USP 1.25 mg (equivalent to 50,000 USP units of Vitamin D)
Protriptyline HCl Tablets, USP 5 mg
Protriptyline HCl Tablets, USP 10 mg
Amiloride Hydrochloride Tablets, USP 5 mg
- Product Pipeline
- Approved Products
| Products | Submitted Approved Launched |
| SPL001 (Amiloride Hydrochloride Tablets) | |
| SPL002 (Protriptyline HCl Tablets) | |
| SPL003 (Ergocalciferol Capsules) | |
| SPL004 (Disulfiram Tablets) | |
| SPL005 | |
| SPL006 (Flucytosine Capsules) | |
| SPL007 (Adefovir Dipivoxil Tablets) | |
| SPL008 | |
| SPL009 | |
| SPL010 |
| Products approved | |||
| Products granted Priority Review Status by the FDA | |||
| Paragraph IV filings |
Approved / Marketed products
Flucytosine Capsules, USP 250 mg
Flucytosine Capsules, USP 500 mg
Disulfiram Tablets, USP 250 mg
Disulfiram Tablets, USP 500 mg
Ergocalciferol Capsules, USP 1.25 mg (equivalent to 50,000 USP units of Vitamin D)
Protriptyline HCl Tablets, USP 5 mg
Protriptyline HCl Tablets, USP 10 mg
Amiloride Hydrochloride Tablets, USP 5 mg
